BIFIDOBACTERIUM AND LACTOBACILLUS CONSORTIUM USED FOR PREPARING BACTERIAL PREPARATIONS, FERMENTS FOR FERMENTED-MILK FOODSTUFFS, FERMENTED AND NONFERMENTED FOODSTUFFS, BIOLOGICALLY ACTIVE SUPPLEMENTS DESIGNATED FOR CORRECTION OF MICROFLORA IN CHILDREN OF AGE FROM 3 TO 12 YEARS

biotechnology, food and medicinal industry. SUBSTANCE: invention proposes the consortium of bifidobacteria and lactobacilli Bifidobacterium bifidum 1, B. bifidum 791, B. breve 79-88, B. infantis 79-43, B. longum B379M, Lactobacillus plantarum 8-PA-3, L. fermentum 90-TC-4, Lactobacillus acidophilus K...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ALESHKIN V.A, AMERKHANOVA A.M
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA DAIRY PRODUCTS, e.g. MILK, BUTTER, CHEESE ENZYMOLOGY FOODS OR FOODSTUFFS HUMAN NECESSITIES HYGIENE MAKING THEREOF MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MILK OR CHEESE SUBSTITUTES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	biotechnology, food and medicinal industry. SUBSTANCE: invention proposes the consortium of bifidobacteria and lactobacilli Bifidobacterium bifidum 1, B. bifidum 791, B. breve 79-88, B. infantis 79-43, B. longum B379M, Lactobacillus plantarum 8-PA-3, L. fermentum 90-TC-4, Lactobacillus acidophilus K3sh24 from GKNM MNIIEM named after G. N. Gabritchevsky, N 160, used for preparing bacterial preparations, ferments for fermented-milk foodstuffs, fermented and nonfermented foodstuffs, biologically active supplements. The consortium is designated for correction of microflora in children of age from 3 to 12 years. The consortium is designated for correction of microflora in intestine, mucosa, opened cavities and cutaneous integuments in children of age from 3 to 12 years, it shows immunocorrecting effect and provides the enhanced protective, immunotropic, metabolic and digestive functions due to synergetic effect of bifidobacterium and lactobacillus components of consortium stimulating the growth of normal microflora. EFFECT: enhanced effectiveness of consortium, expanded assortment of curative- prophylactic agents. 3 tbl, 5 ex